Background Inherited risk is a family issue. Identifying family members who carry a
pathogenic genetic variant that increases risk of cancers and other chronic diseases can be …

Background Population-based cancer genetic family history (FH) screening to identify
families at high risk for BRCA-associated cancers has been endorsed by national public …

(1) Background: Genomic testing is increasingly utilized as a clinical tool; however, its
integration into nephrology remains limited. The purpose of this study was to identify barriers …

Genetic counseling and testing (GCT) inform cancer management for persons at risk for
hereditary breast and ovarian cancer (HBOC). Community‐based organizations (CBOs) may …

Introduction: Encouraging family communication about possible genetic risk has become
among the most important avenues for achieving the full potential of genomic discovery for …

The collection and evaluation of family health history in a clinical setting presents an
opportunity to discuss cancer risk, tailor cancer screening recommendations, and identify …

Cancer genomic services (CGS) can support genetic risk‐stratified cancer prevention and
treatment. Racial/ethnic minority groups are less likely to access and utilize CGS compared …

Introduction: There is widespread under-identification of individuals at hereditary cancer risk
despite national guidelines calling for screening. We evaluated the utilization of a tool …

Georgia implemented a statewide family history screening program for hereditary breast and
ovarian cancer. From November 2012 through December 2020, 29 090 individuals were …

Genomics-informed applications with evidence to support health benefit are not being
equitably distributed [1‒3]. This is bearing out very clearly in the context of cancer. Evidence …